Evaluating the Durability of Closure for Diabetic Foot Ulcers Following a Randomized, Controlled, Modified Platform Trial.

Last updated: February 9, 2026
Sponsor: Applied Biologics, LLC
Overall Status: Active - Recruiting

Phase

N/A

Condition

Diabetes Mellitus, Type 2

Pressure Ulcer

Ulcers

Treatment

Blue Drop Foot Scanner

Clinical Study ID

NCT07360418
Pro00084454
  • Ages > 18
  • All Genders

Study Summary

Prospective long-term follow-up on durability of closure evaluated by photographic and thermal scanning.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • The potential subject must have participated in the CAMPX trial and achievedcomplete closure by the 12-week endpoint.

Exclusion

Exclusion Criteria:

  • The potential subject did not participate in the CAMPX trial.

  • The potential subject participated in the CAMPX trial and did not achieve completeclosure.

Study Design

Total Participants: 50
Treatment Group(s): 1
Primary Treatment: Blue Drop Foot Scanner
Phase:
Study Start date:
October 16, 2025
Estimated Completion Date:
October 31, 2027

Study Description

This study is a follow-up durability trial from the CAMPX randomized controlled clinical trial. Only subjects who achieved complete closure at 12 weeks in the CAMPX trial will be evaluated. After signing the IRB-approved informed consent form, the subject will receive instruction on the BlueDrop® OneStep Foot Scanner™. In addition, written instructions on use will be provided. Subjects that are unable to use the scale will be asked to answer a questionnaire at 3, 6, 9, and 12 months after signing the consent form..

Connect with a study center

  • Detroit Foot and Ankle

    Clinton Township 4989133, Michigan 5001836 48038
    United States

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.